Literature DB >> 16950057

A randomized prospective evaluation of outcomes after total hip arthroplasty using cross-linked marathon and non-cross-linked Enduron polyethylene liners.

C Anderson Engh1, Adam S Stepniewski, Stuart D Ginn, Sarah E Beykirch, Christi J Sychterz-Terefenko, Robert H Hopper, Charles A Engh.   

Abstract

Cross-linked liners were introduced with the promise that they would substantially reduce polyethylene wear. In 1999, our institution initiated a prospective study to compare the outcome of total hip arthroplasty patients who were randomized to non-cross-linked Enduron liners with that of total hip arthroplasty patients who were randomized to Marathon polyethylene liners that had been cross-linked with 5 Mrad (50 kGy) of gamma-irradiation and heat-treated to eliminate free radicals. At a mean follow-up of 5.7 years, the clinical outcomes among the Marathon and Enduron liners were similar. However, the mean wear rate was 0.01 +/- 0.07 mm/y for the Marathon group, which represents a 95% reduction compared with the mean wear rate of 0.19 +/- 0.12 mm/y for the Enduron group. In addition, the incidence of osteolysis was lower in the Marathon group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950057     DOI: 10.1016/j.arth.2006.05.002

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  42 in total

1.  The John Charnley Award: an accurate and sensitive method to separate, display, and characterize wear debris: part 1: polyethylene particles.

Authors:  Fabrizio Billi; Paul Benya; Aaron Kavanaugh; John Adams; Edward Ebramzadeh; Harry McKellop
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

2.  The incidence of acetabular osteolysis in young patients with conventional versus highly crosslinked polyethylene.

Authors:  Nathan A Mall; Ryan M Nunley; Jin Jun Zhu; William J Maloney; Robert L Barrack; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

3.  Highly crosslinked polyethylene reduces wear in total hip arthroplasty at 5 years.

Authors:  Jonathan Mutimer; Peter A Devane; Kathryn Adams; J Geoffrey Horne
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

4.  Wear is reduced in THA performed with highly cross-linked polyethylene.

Authors:  Burak Beksaç; Antonio Salas; Alejandro González Della Valle; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-12-12       Impact factor: 4.176

Review 5.  A systematic review of radiological outcomes of highly cross-linked polyethylene versus conventional polyethylene in total hip arthroplasty.

Authors:  Zongyou Mu; Jialiang Tian; Taixiang Wu; Jing Yang; Fuxing Pei
Journal:  Int Orthop       Date:  2009-01-29       Impact factor: 3.075

6.  Early failure of a cross-linked polyethylene acetabular liner. A case report.

Authors:  K David Moore; Preston R Beck; Donald W Petersen; John M Cuckler; Jack E Lemons; Alan W Eberhardt
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

7.  Wear and Osteolysis of Highly Crosslinked Polyethylene at 10 to 14 Years: The Effect of Femoral Head Size.

Authors:  Paul F Lachiewicz; Elizabeth S Soileau; John M Martell
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

8.  High stress conditions do not increase wear of thin highly crosslinked UHMWPE.

Authors:  Natalie H Kelly; Amar D Rajadhyaksha; Timothy M Wright; Suzanne A Maher; Geoffrey H Westrich
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

9.  Characteristics of highly cross-linked polyethylene wear debris in vivo.

Authors:  Ryan M Baxter; Daniel W MacDonald; Steven M Kurtz; Marla J Steinbeck
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-02-22       Impact factor: 3.368

10.  THA with highly cross-linked polyethylene in patients 50 years or younger.

Authors:  Derek S Shia; John C Clohisy; Mark F Schinsky; John M Martell; William J Maloney
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.